Olanzapine Pamoate 71161-0143
Product NDC
71161-0143- Manufacturer
- Synergy Health Ast, Llc
- Dosage Form
- Injection, Powder, For Suspension, Extended Release
- Product Type
- Drug For Further Processing
- Marketing Start
- December 11, 2009
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olanzapine Pamoate | 300 mg/2mL |
Packaging Options(1)
2 mL in 1 VIAL (71161-143-01)